NCT00522795View on ClinicalTrials.gov

Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions
Esophageal Cancer
Interventions
DRUG

PPX with cisplatin and radiation

weekly IV treatment of Paclitaxel Poliglumex and Cisplatin for 6 weeks

Trial Locations (1)

02903

Lifespan Hospitals, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

Brown University

OTHER

NCT00522795 - Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001) | Biotech Hunter | Biotech Hunter